Go SearchAdvanced Search
Do More to Stay Healthy: View tips for healthy living past menopause

EVISTA is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis.

It’s important to know that osteoporosis and invasive breast cancer are more common after menopause. You are already treating your osteoporosis, and as a woman past menopause, you may also wonder about your risk of invasive breast cancer. Invasive breast cancer, the most common form of breast cancer, is cancer that has spread beyond its initial site into other breast tissue, or even other parts of the body. One in 8 women will get invasive breast cancer in her lifetime (EVISTA is only indicated to reduce the risk of invasive breast cancer in women past menopause).

If you already have or have had breast cancer, EVISTA does not treat it or prevent its return, and it does not reduce the risk of all forms of breast cancer.

Invasive Breast Cancer Risk Factors
The risk factors for invasive breast cancer include:

  • Family history: If your mother, sister, or daughter has been diagnosed, the risk is increased. The risk is greater if she was diagnosed before the age of 50
  • Previous breast biopsy, even if the results were normal
  • First live birth after age 30, or never giving birth
  • First period before age 12
  • Increased breast density
  • Age: 2 out of 3 women diagnosed with invasive breast cancer are age 55 or older
Next: Know More About Osteoporosis

Indication for EVISTA® (raloxifene HCI tablets)
EVISTA is indicated for the treatment of osteoporosis and for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis.

If you already have or have had breast cancer, EVISTA does not treat it or prevent its return, and it does not reduce the risk of all forms of breast cancer.

Indication for EVISTA® (raloxifene HCI tablets)
EVISTA is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

Indication for EVISTA® (raloxifene HCI tablets)
EVISTA is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.

If you already have or have had breast cancer, EVISTA does not treat it or prevent its return, and it does not reduce the risk of all forms of breast cancer.

Indications for EVISTA® (raloxifene HCI tablets)
EVISTA is indicated for:

  • The treatment and prevention of osteoporosis in postmenopausal women
  • The reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis
  • The reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer

If you already have or have had breast cancer, EVISTA does not treat it or prevent its return, and it does not reduce the risk of all forms of breast cancer.

Important Safety Information About EVISTA

You should not take EVISTA if you have had or are at risk for getting blood clots in the legs, lungs or eyes, as it may increase the risk of blood clots. Stop taking EVISTA and call your doctor if you have leg pain or warmth, swelling of the legs, hands or feet, chest pain, shortness of breath or a sudden vision change, as these may be signs of a blood clot. Being unable to move around for long periods may increase this risk. If you will need to be still for a long time, talk to your doctor about ways to reduce the risk of blood clots.

EVISTA does not increase the risk of a heart attack or stroke in women who have had or are at risk for a heart attack; however; EVISTA increases the likelihood of dying from stroke in these women, should one occur. Before taking EVISTA tell your doctor if you have had a stroke, a mini-stroke, irregular heartbeat, high blood pressure, heart attack, history of smoking, or believe you have other risk factors for stroke or a heart attack.

Before Taking EVISTA

EVISTA is not right for everyone. You should only take prescription EVISTA if you are past menopause. Before taking EVISTA, talk to your doctor about all your medical conditions. If you are pregnant, nursing or may become pregnant, do not take EVISTA, as it may cause fetal harm. Women with liver or kidney disease should use EVISTA with caution. EVISTA should not be taken with estrogens in the form of pills, patches or injections.

Side Effects

Side effects may include hot flashes, leg cramps, swelling, flu-like symptoms, joint pain, and sweating. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more safety information, please see the Medication Guide and full Prescribing Information.